Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Depression
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Depression
    Escitalopram Decreases Symptoms of Major Depressive Disorder in Adolescents: Presented at AACAP - (DGDispatch)
    TopAbstracts in Depression 11/04/2009 - (DGNews)
    TopAbstracts in Depression 10/29/2009 - (DGNews)
    Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial - (JAMA)
    TopAbstracts in Depression 10/21/2009 - (DGNews)

    News archive

     Recent webcasts/CME - Depression
    Antidepressant-Induced Suicidality: Implications for Clinical Practice
    Treatment-Resistant Depression -- Part III: Switching Antidepressants vs. Conventional Augmentation Strategies

    Webcasts/CME archive

     Recent cases - Depression
      Creutzfeldt-Jacob Disease Presenting as Severe Depression: A Case Report
      Sexual Dysfunction in a Young Mother
      Psychiatric Disorder Associated with Vacuum-Assisted Breast Biopsy Clip Placement: A Case Report
      A Postmenopausal Woman Presenting with Ekbom Syndrome Associated with Recurrent Depressive Disorder: A Case Report
      Affective Psychosis, Hashimoto's Thyroiditis, and Brain Perfusion Abnormalities: Case Report

      Cases archive
        




      my personal edition > depression > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Sertraline And Imipramine Reduce Anxiety In Depressed Patients

      A DGReview of :"Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression"
      Depression and Anxiety

      03/15/2001
      By Mark Greener


      Both sertraline and imipramine reduce concurrent anxiety in depressed patients.

      Anxiety complicates the clinical presentation of many cases of depression and may be associated with a worse outcome over the longer term. However, the clinical correlates of subsyndromic or secondary anxiety as well as the treatment responses of these syndromes are poorly characterised.

      Against this background, researchers from the University of Texas Medical Branch at Galveston and a number of other American centres treated 209 patients presenting using imipramine and 426 patients using sertraline. All patients had chronic major or double depression; 36 percent showed high levels of anxiety on the Hamilton Rating Scale for Depression (HAM-D) anxiety/somatization factor with scores of at least 7.

      Kaplan-Meier probability estimates suggested that patients with significant anxiety were more likely to respond after 12 week's treatment than patients who did not have significant anxiety symptoms (66.4 and 54.2 percent, respectively). Response rates for sertraline and imipramine did not differ significantly.

      Both sertraline and imipramine reduced high levels of anxiety at baseline. For example, 60 and 58 percent of patients, respectively, showed at least a halving in baseline HAM-D anxiety and somatization scores. Only 4.6 and 9.9 percent, respectively, experienced worsening anxiety. Moreover, acute treatment with either drug improved scores on measures of psychosocial functioning and quality of life.

      The authors note that high baseline anxiety was not associated with a reduced overall response to antidepressants. However, high baseline anxiety delayed the onset of response in patients with chronic depression.
      Depression and Anxiety 2001;13:18-27. "Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression"

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send